Selskabets formål er at drive speciallægevirksomhed indenfor øre-næse-halsspecialet og virksomhed, der er naturligt forbundet hermed
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 4.5 mio. | 271 t. | 1.7 mio. | 434 t. | 3 | |
CVR: 32155014
Compared to 624 companies in Speciallægers aktiviteter
Comparison is based on industry median values
Companies in the same industry and area
CVR 34435383
CVR 35604847
CVR 38443739
CVR 10875277
CVR 16483400
The company demonstrates a positive financial trajectory, with revenue increasing from 3,520,063 DKK in 2022 to 4,463,480 DKK in 2025, reflecting a strong growth trend. Profitability has also improved, with a notable profit of 270,698 DKK in 2025, up from a loss of 31,816 DKK in 2022. Equity has steadily increased, reaching 434,417 DKK, indicating a strengthening financial position. However, the company has a relatively low equity base compared to its revenue, which could raise concerns about financial stability in the long term. Overall, it appears to be well-positioned within the specialized medical services industry, benefiting from consistent demand.
AI-generated summary
companydata.dk